Pfizer mRNA Vaccine - Search News

Novavax to Move Forward With Covid-19-Flu Vaccine

FDA Gives Green Signal To Novavax's COVID-19-Influenza Combo Vaccine Late-Stage Trial

On Monday, the FDA removed the clinical hold on Novavax Inc.’s (NASDAQ:NVAX) Investigational New Drug (IND) application for its COVID-19-influenza combination (CIC) and stand-alone influenza vaccine candidates.

MarketWatch · 3h

Novavax to Move Forward With Covid-19-Flu Vaccine After FDA Lifts Clinical Hold -- Update

Novavax can move forward with a trial for its combined Covid-19 and influenza vaccine after regulators lifted a clinical hold. The Gaithersburg, Md., vaccine developer said Monday that the U.S. Food and Drug Administration had removed the clinical hold on its investigational new drug application for its combined vaccine and its standalone flu vaccine candidates.

Business Insider · 3h

FDA Lifts Clinical Hold On Novavax COVID-19-Influenza Combo Vaccine Candidate; Stock Up

Monday said the Food and Drug Administration or FDA has removed the clinical hold on its COVID-19-Influenza Combination (CIC) and stand-alone influenza vaccine candidates. Novavax shares were up more than 13 percent in pre-market.

pharmaphorum3d

Pfizer, BioNTech's mRNA flu vaccine starts phase 3 testing

Moderna – at the moment embroiled in a patent dispute with Pfizer and BioNTech over mRNA intellectual property – is also testing a vaccine that combines COVID-19 and flu in a single jab in a ...

Hosted on MSN3d

Pfizer, GSK, Moderna struggle in a shrinking RSV vaccine market

Moderna’s (NASDAQ:MRNA) Q3 results confirmed on Thursday that the U.S. vaccine market for respiratory syncytial virus ...

12d

Moderna, Pfizer or Novavax? How the three Covid-19 vaccines differ according to Yale Medicine

In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three vaccines available in the U.S.

Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market Share Concerns, Analysts Warn

Moderna's stock faces a decline as analysts lower the price target to $90, citing weaker vaccine demand and concerns over ...

NBC 10 Philadelphia17d

Fact Check: Q&A on the 2024-2025 COVID-19 Vaccines

On Aug. 22, the Food and Drug Administration approved and authorized newer formulations of the two mRNA vaccines, from ...

Canada approves Moderna's RSV vaccine for adults aged 60 and older

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

12don MSN

Florida’s 2024-2025 COVID-19 Vaccine Guidance Misunderstands, Distorts Existing Science

1-lineage omicron variants of the coronavirus, or SARS-CoV-2. The options include the mRNA vaccines from ...

NBC News on MSN8d

Some people will need an extra Covid vaccine in the spring

How durable are the mRNA Covid vaccines? Does the protection last as long as other vaccines? Experts the vaccines are performing as expected.

NBC Los Angeles8d

Do the Covid vaccines provide long-lasting protection?

the mRNA vaccines from Pfizer and Moderna — aren’t effective. Get top local stories in Southern California delivered to ...

FiercePharma7d

BioNTech reports surprising COVID vaccine sales in Q3 but tempers expectations for annual sales

Despite the performance, the company expects to be at the lower end of its revenue guidance window for the year of between €2 ...

health.wusf.usf.edu13d

Which vaccines should Florida residents get for fall and winter protection?

Anyone with COVID-19 during the summer has some, but not full, protection against germs spreading in fall and winter.

Hosted on MSN1d

Should Kids Get the COVID-19 Vaccine?

Novavax is approved for children aged 12 and older. Both Moderna and Pfizer-BioNTech vaccines use messenger RNA (mRNA), ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results